FGF23 and Nephropathy: The objective of this study was to investigate whether childhood cancer treatment affects the levels of soluble α-Klotho and fibroblast growth factor-23 in survivors of childhood cancer several years after treatment, as well as their relationship to kidney damage and cardiovascular disease.